A Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium CEP of the European Pharmacopoeia monograph is often referred to as a Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium Certificate of Suitability (COS). The purpose of a Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium to their clients by showing that a Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium CEP has been issued for it. The manufacturer submits a Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium CEP holder for the record. Additionally, the data presented in the Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium DMF.
A Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Voltaren, Solaraze, Ecofenac, Benfofen, Diclofenac sodium suppliers with CEP (COS) on PharmaCompass.